Pillstats
Rx only · Capsule, Delayed Release Pellets · Oral

Verapamil Hydrochloride

Verapamil Hydrochloride

0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
0 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)11170
US makers2 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.06$2.13$3.19$4.26Dec 2025Apr 2026Jul 2026
$3.100
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
0
Active US suppliers

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.6K7.2K11K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
880
Rx · 2026 Q1
38K
Units dispensed
-93%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it0 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown4EXITED 2026
Bryant Ranch Prepackrepackager1EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.